跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
bispecific antibody (follicular lymphoma)
首页
药物
bispecific antibody (follicular lymphoma)
bispecific antibody (follicular lymphoma)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
HUMAN ANTIBODIES THAT BIND CD19 AND USES THEREOF
申请人: MEDAREX INC
优先权: 2007
US
Bispecific antibody therapy of lymphoid malignancy conditions
申请人: CELGENE CORP
优先权: 2020
CN
Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
申请人: GENMAB AS
优先权: 2021
US
Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
申请人: GENMAB AS
优先权: 2021
US
药物
反馈
